{
  "fields": [{"id":"_id","type":"int"},{"id":"KpiId","type":"text","info":{"label":"KpiId"}},{"id":"KpiName","type":"text","info":{"label":"KpiName"}},{"id":"Value","type":"text","info":{"label":"Value"}},{"id":"DataType","type":"text","info":{"label":"DataType"}},{"id":"Period","type":"text","info":{"label":"Period"}},{"id":"StartDate","type":"text","info":{"label":"StartDate"}},{"id":"EndDate","type":"text","info":{"label":"EndDate"}},{"id":"CollectionFrequency","type":"text","info":{"label":"CollectionFrequency"}}],
  "records": [
    [1,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","30.90 %","Percentage","2013/2014_Q1","2013-04-01","2013-06-30","Quarterly"],
    [2,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","34.60 %","Percentage","2013/2014","2013-04-01","2014-03-31","Quarterly"],
    [3,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","31.10 %","Percentage","2013/2014_Q2","2013-07-01","2013-09-30","Quarterly"],
    [4,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","30.50 %","Percentage","2013/2014_Q3","2013-10-01","2013-12-31","Quarterly"],
    [5,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","34.60 %","Percentage","2013/2014_Q4","2014-01-01","2014-03-31","Quarterly"],
    [6,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","36.50 %","Percentage","2014/2015_Q1","2014-04-01","2014-06-30","Quarterly"],
    [7,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","40.10 %","Percentage","2014/2015","2014-04-01","2015-03-31","Quarterly"],
    [8,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","35.60 %","Percentage","2014/2015_Q2","2014-07-01","2014-09-30","Quarterly"],
    [9,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","38.80 %","Percentage","2014/2015_Q3","2014-10-01","2014-12-31","Quarterly"],
    [10,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","40.10 %","Percentage","2014/2015_Q4","2015-01-01","2015-03-31","Quarterly"],
    [11,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","38.00 %","Percentage","2015/2016_Q1","2015-04-01","2015-06-30","Quarterly"],
    [12,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","31.10 %","Percentage","2015/2016","2015-04-01","2016-03-31","Quarterly"],
    [13,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","34.80 %","Percentage","2015/2016_Q2","2015-07-01","2015-09-30","Quarterly"],
    [14,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","33.30 %","Percentage","2015/2016_Q3","2015-10-01","2015-12-31","Quarterly"],
    [15,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","31.10 %","Percentage","2015/2016_Q4","2016-01-01","2016-03-31","Quarterly"],
    [16,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","32.51 %","Percentage","2016/2017_Q1","2016-04-01","2016-06-30","Quarterly"],
    [17,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","38.08 %","Percentage","2016/2017","2016-04-01","2017-03-31","Quarterly"],
    [18,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","37.93 %","Percentage","2016/2017_Q2","2016-07-01","2016-09-30","Quarterly"],
    [19,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","37.89 %","Percentage","2016/2017_Q3","2016-10-01","2016-12-31","Quarterly"],
    [20,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","38.08 %","Percentage","2016/2017_Q4","2017-01-01","2017-03-31","Quarterly"],
    [21,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","32.11 %","Percentage","2017/2018","2017-04-01","2018-03-31","Quarterly"],
    [22,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","36.93 %","Percentage","2017/2018_Q1","2017-04-01","2017-06-30","Quarterly"],
    [23,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","33.91 %","Percentage","2017/2018_Q2","2017-07-01","2017-09-30","Quarterly"],
    [24,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.96 %","Percentage","2017/2018_Q3","2017-10-01","2017-12-31","Quarterly"],
    [25,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","32.11 %","Percentage","2017/2018_Q4","2018-01-01","2018-03-31","Quarterly"],
    [26,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.20 %","Percentage","2018/2019","2018-04-01","2019-03-31","Quarterly"],
    [27,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","30.33 %","Percentage","2018/2019_Q1","2018-04-01","2018-06-30","Quarterly"],
    [28,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","26.61 %","Percentage","2018/2019_Q2","2018-07-01","2018-09-30","Quarterly"],
    [29,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","31.50 %","Percentage","2018/2019_Q3","2018-10-01","2018-12-31","Quarterly"],
    [30,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.20 %","Percentage","2018/2019_Q4","2019-01-01","2019-03-31","Quarterly"],
    [31,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","28.71 %","Percentage","2019/2020_Q1","2019-04-01","2019-06-30","Quarterly"],
    [32,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","27.71 %","Percentage","2019/2020","2019-04-01","2020-03-31","Quarterly"],
    [33,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","32.49 %","Percentage","2019/2020_Q2","2019-07-01","2019-09-30","Quarterly"],
    [34,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","31.84 %","Percentage","2019/2020_Q3","2019-10-01","2019-12-31","Quarterly"],
    [35,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","27.71 %","Percentage","2019/2020_Q4","2020-01-01","2020-03-31","Quarterly"],
    [36,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.30 %","Percentage","2020/2021","2020-04-01","2021-03-31","Quarterly"],
    [37,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.30 %","Percentage","2020/2021_Q1","2020-04-01","2020-06-30","Quarterly"],
    [38,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","27.67 %","Percentage","2020/2021_Q2","2020-07-01","2020-09-30","Quarterly"],
    [39,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","28.97 %","Percentage","2020/2021_Q3","2020-10-01","2020-12-31","Quarterly"],
    [40,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.30 %","Percentage","2020/2021_Q4","2021-01-01","2021-03-31","Quarterly"],
    [41,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","26.50 %","Percentage","2021/2022","2021-04-01","2022-03-31","Quarterly"],
    [42,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","27.61 %","Percentage","2021/2022_Q1","2021-04-01","2021-06-30","Quarterly"],
    [43,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.70 %","Percentage","2021/2022_Q2","2021-07-01","2021-09-30","Quarterly"],
    [44,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","28.73 %","Percentage","2021/2022_Q3","2021-10-01","2021-12-31","Quarterly"],
    [45,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","26.50 %","Percentage","2021/2022_Q4","2022-01-01","2022-03-31","Quarterly"],
    [46,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","20.00 %","Percentage","2022/2023","2022-04-01","2023-03-31","Quarterly"],
    [47,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","24.78 %","Percentage","2022/2023_Q1","2022-04-01","2022-06-30","Quarterly"],
    [48,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","21.40 %","Percentage","2022/2023_Q2","2022-07-01","2022-09-30","Quarterly"],
    [49,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","19.92 %","Percentage","2022/2023_Q3","2022-10-01","2022-12-31","Quarterly"],
    [50,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","20.00 %","Percentage","2022/2023_Q4","2023-01-01","2023-03-31","Quarterly"],
    [51,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","21.99 %","Percentage","2023/2024_Q1","2023-04-01","2023-06-30","Quarterly"],
    [52,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","19.52 %","Percentage","2023/2024","2023-04-01","2024-03-31","Quarterly"],
    [53,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","22.22 %","Percentage","2023/2024_Q2","2023-07-01","2023-09-30","Quarterly"],
    [54,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","23.30 %","Percentage","2023/2024_Q3","2023-10-01","2023-12-31","Quarterly"],
    [55,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","19.52 %","Percentage","2023/2024_Q4","2024-01-01","2024-03-31","Quarterly"],
    [56,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","16.50 %","Percentage","2024/2025_Q1","2024-04-01","2024-06-30","Quarterly"],
    [57,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","17.14 %","Percentage","2024/2025","2024-04-01","2025-03-31","Quarterly"],
    [58,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","17.70 %","Percentage","2024/2025_Q2","2024-07-01","2024-09-30","Quarterly"],
    [59,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","15.84 %","Percentage","2024/2025_Q3","2024-10-01","2024-12-31","Quarterly"],
    [60,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","17.14 %","Percentage","2024/2025_Q4","2025-01-01","2025-03-31","Quarterly"],
    [61,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","18.72 %","Percentage","2025/2026_Q1","2025-04-01","2025-06-30","Quarterly"],
    [62,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","23.59 %","Percentage","2025/2026_Q2","2025-07-01","2025-09-30","Quarterly"],
    [63,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","30.90 %","Percentage","2013/2014_Q1","2013-04-01","2013-06-30","Quarterly"],
    [64,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","34.60 %","Percentage","2013/2014","2013-04-01","2014-03-31","Quarterly"],
    [65,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","31.10 %","Percentage","2013/2014_Q2","2013-07-01","2013-09-30","Quarterly"],
    [66,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","30.50 %","Percentage","2013/2014_Q3","2013-10-01","2013-12-31","Quarterly"],
    [67,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","34.60 %","Percentage","2013/2014_Q4","2014-01-01","2014-03-31","Quarterly"],
    [68,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","36.50 %","Percentage","2014/2015_Q1","2014-04-01","2014-06-30","Quarterly"],
    [69,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","40.10 %","Percentage","2014/2015","2014-04-01","2015-03-31","Quarterly"],
    [70,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","35.60 %","Percentage","2014/2015_Q2","2014-07-01","2014-09-30","Quarterly"],
    [71,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","38.80 %","Percentage","2014/2015_Q3","2014-10-01","2014-12-31","Quarterly"],
    [72,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","40.10 %","Percentage","2014/2015_Q4","2015-01-01","2015-03-31","Quarterly"],
    [73,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","38.00 %","Percentage","2015/2016_Q1","2015-04-01","2015-06-30","Quarterly"],
    [74,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","31.10 %","Percentage","2015/2016","2015-04-01","2016-03-31","Quarterly"],
    [75,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","34.80 %","Percentage","2015/2016_Q2","2015-07-01","2015-09-30","Quarterly"],
    [76,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","33.30 %","Percentage","2015/2016_Q3","2015-10-01","2015-12-31","Quarterly"],
    [77,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","31.10 %","Percentage","2015/2016_Q4","2016-01-01","2016-03-31","Quarterly"],
    [78,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","32.51 %","Percentage","2016/2017_Q1","2016-04-01","2016-06-30","Quarterly"],
    [79,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","38.08 %","Percentage","2016/2017","2016-04-01","2017-03-31","Quarterly"],
    [80,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","37.93 %","Percentage","2016/2017_Q2","2016-07-01","2016-09-30","Quarterly"],
    [81,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","37.89 %","Percentage","2016/2017_Q3","2016-10-01","2016-12-31","Quarterly"],
    [82,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","38.08 %","Percentage","2016/2017_Q4","2017-01-01","2017-03-31","Quarterly"],
    [83,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","32.11 %","Percentage","2017/2018","2017-04-01","2018-03-31","Quarterly"],
    [84,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","36.93 %","Percentage","2017/2018_Q1","2017-04-01","2017-06-30","Quarterly"],
    [85,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","33.91 %","Percentage","2017/2018_Q2","2017-07-01","2017-09-30","Quarterly"],
    [86,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.96 %","Percentage","2017/2018_Q3","2017-10-01","2017-12-31","Quarterly"],
    [87,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","32.11 %","Percentage","2017/2018_Q4","2018-01-01","2018-03-31","Quarterly"],
    [88,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.20 %","Percentage","2018/2019","2018-04-01","2019-03-31","Quarterly"],
    [89,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","30.33 %","Percentage","2018/2019_Q1","2018-04-01","2018-06-30","Quarterly"],
    [90,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","26.61 %","Percentage","2018/2019_Q2","2018-07-01","2018-09-30","Quarterly"],
    [91,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","31.50 %","Percentage","2018/2019_Q3","2018-10-01","2018-12-31","Quarterly"],
    [92,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.20 %","Percentage","2018/2019_Q4","2019-01-01","2019-03-31","Quarterly"],
    [93,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","28.71 %","Percentage","2019/2020_Q1","2019-04-01","2019-06-30","Quarterly"],
    [94,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","27.71 %","Percentage","2019/2020","2019-04-01","2020-03-31","Quarterly"],
    [95,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","32.49 %","Percentage","2019/2020_Q2","2019-07-01","2019-09-30","Quarterly"],
    [96,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","31.84 %","Percentage","2019/2020_Q3","2019-10-01","2019-12-31","Quarterly"],
    [97,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","27.71 %","Percentage","2019/2020_Q4","2020-01-01","2020-03-31","Quarterly"],
    [98,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.30 %","Percentage","2020/2021","2020-04-01","2021-03-31","Quarterly"],
    [99,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.30 %","Percentage","2020/2021_Q1","2020-04-01","2020-06-30","Quarterly"],
    [100,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","27.67 %","Percentage","2020/2021_Q2","2020-07-01","2020-09-30","Quarterly"],
    [101,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","28.97 %","Percentage","2020/2021_Q3","2020-10-01","2020-12-31","Quarterly"],
    [102,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.30 %","Percentage","2020/2021_Q4","2021-01-01","2021-03-31","Quarterly"],
    [103,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","26.50 %","Percentage","2021/2022","2021-04-01","2022-03-31","Quarterly"],
    [104,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","27.61 %","Percentage","2021/2022_Q1","2021-04-01","2021-06-30","Quarterly"],
    [105,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","29.70 %","Percentage","2021/2022_Q2","2021-07-01","2021-09-30","Quarterly"],
    [106,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","28.73 %","Percentage","2021/2022_Q3","2021-10-01","2021-12-31","Quarterly"],
    [107,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","26.50 %","Percentage","2021/2022_Q4","2022-01-01","2022-03-31","Quarterly"],
    [108,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","20.00 %","Percentage","2022/2023","2022-04-01","2023-03-31","Quarterly"],
    [109,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","24.78 %","Percentage","2022/2023_Q1","2022-04-01","2022-06-30","Quarterly"],
    [110,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","21.40 %","Percentage","2022/2023_Q2","2022-07-01","2022-09-30","Quarterly"],
    [111,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","19.92 %","Percentage","2022/2023_Q3","2022-10-01","2022-12-31","Quarterly"],
    [112,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","20.00 %","Percentage","2022/2023_Q4","2023-01-01","2023-03-31","Quarterly"],
    [113,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","21.99 %","Percentage","2023/2024_Q1","2023-04-01","2023-06-30","Quarterly"],
    [114,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","19.52 %","Percentage","2023/2024","2023-04-01","2024-03-31","Quarterly"],
    [115,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","22.22 %","Percentage","2023/2024_Q2","2023-07-01","2023-09-30","Quarterly"],
    [116,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","23.30 %","Percentage","2023/2024_Q3","2023-10-01","2023-12-31","Quarterly"],
    [117,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","19.52 %","Percentage","2023/2024_Q4","2024-01-01","2024-03-31","Quarterly"],
    [118,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","16.50 %","Percentage","2024/2025_Q1","2024-04-01","2024-06-30","Quarterly"],
    [119,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","17.14 %","Percentage","2024/2025","2024-04-01","2025-03-31","Quarterly"],
    [120,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","17.70 %","Percentage","2024/2025_Q2","2024-07-01","2024-09-30","Quarterly"],
    [121,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","15.84 %","Percentage","2024/2025_Q3","2024-10-01","2024-12-31","Quarterly"],
    [122,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","17.14 %","Percentage","2024/2025_Q4","2025-01-01","2025-03-31","Quarterly"],
    [123,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","18.72 %","Percentage","2025/2026_Q1","2025-04-01","2025-06-30","Quarterly"],
    [124,"PHOF77","% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)","23.59 %","Percentage","2025/2026_Q2","2025-07-01","2025-09-30","Quarterly"]
]}